BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27789676)

  • 21. [Prognostic value of the revised international staging system for newly diagnosed multiple myeloma patients].
    Lu J; Du J; Fu WJ; He HY; Li L; Li R; Zhou LL; Jiang H; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2017 Jun; 38(6):475-479. PubMed ID: 28655089
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination of Genetic Aberration With International Staging System Classification for Stratification of Asian Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation.
    Byun JM; Kim D; Shin DY; Kim I; Koh Y; Yoon SS
    In Vivo; 2019; 33(2):611-619. PubMed ID: 30804149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma.
    Gupta R; Kaur G; Kumar L; Rani L; Mathur N; Sharma A; Dahiya M; Shekhar V; Khan S; Mookerjee A; Sharma OD
    Ann Hematol; 2018 Dec; 97(12):2447-2454. PubMed ID: 30056581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LDH is an adverse prognostic factor independent of ISS in transplant-eligible myeloma patients receiving bortezomib-based induction regimens.
    Chim CS; Sim J; Tam S; Tse E; Lie AK; Kwong YL
    Eur J Haematol; 2015 Apr; 94(4):330-5. PubMed ID: 25135740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The applicability of the Second Revision of the International Staging System for patients with multiple myeloma receiving immunomodulatory drugs or proteasome inhibitor-based regimens as induction treatment: A real-world analysis.
    Chen H; Zhou N; Hu X; Wang D; Wei W; Peng R; Chen X; Shi H; Wu L; Yu W; Zhao W; Zhou F
    Hematol Oncol; 2023 Feb; 41(1):139-146. PubMed ID: 36252280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.
    Avet-Loiseau H; Durie BG; Cavo M; Attal M; Gutierrez N; Haessler J; Goldschmidt H; Hajek R; Lee JH; Sezer O; Barlogie B; Crowley J; Fonseca R; Testoni N; Ross F; Rajkumar SV; Sonneveld P; Lahuerta J; Moreau P; Morgan G;
    Leukemia; 2013 Mar; 27(3):711-7. PubMed ID: 23032723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An abnormal nonhyperdiploid karyotype is a significant adverse prognostic factor for multiple myeloma in the bortezomib era.
    Tan D; Teoh G; Lau LC; Lim A; Lim TH; Yap KC; Premalatha P; Lao ZT; Wee N; Choo C; Wee HC; Su S; Lee YS; Lee LH; Hwang W; Goh YT
    Am J Hematol; 2010 Oct; 85(10):752-6. PubMed ID: 20721886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum-free light chains combined with the Revised International Staging System could further distinguish the superior and inferior clinical outcome of multiple myeloma patients.
    Du J; Lu J; Gao W; Liu J; He H; Li L; Li R; Zhou L; Jiang H; Chen W; Fu W; Hou J
    Ann Hematol; 2020 Aug; 99(8):1779-1791. PubMed ID: 32594218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.
    Sagaster V; Kaufmann H; Odelga V; Ackermann J; Gisslinger H; Rabitsch W; Zojer N; Ludwig H; Nösslinger T; Zielinski C; Drach J
    Eur J Haematol; 2007 Mar; 78(3):227-34. PubMed ID: 17253972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
    Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
    Kastritis E; Zervas K; Symeonidis A; Terpos E; Delimbassi S; Anagnostopoulos N; Michali E; Zomas A; Katodritou E; Gika D; Pouli A; Christoulas D; Roussou M; Kartasis Z; Economopoulos T; Dimopoulos MA
    Leukemia; 2009 Jun; 23(6):1152-7. PubMed ID: 19225533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical Application of R-ISS Staging System in 412 Newly Diagnosed Patients with Multiple Myeloma].
    Chen HM; Wei W; Peng R; Shi HT; Chen XL; Wu LX; Zhou N; Zhou F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):110-114. PubMed ID: 30738456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and outcomes of patients with multiple myeloma aged 21-40 years versus 41-60 years: a multi-institutional case-control study.
    Jurczyszyn A; Nahi H; Avivi I; Gozzetti A; Niesvizky R; Yadlapati S; Jayabalan DS; Robak P; Pika T; Andersen KT; Rasche L; Mądry K; Woszczyk D; Raźny M; Usnarska-Zubkiewicz L; Knopińska-Posłuszny W; Wojciechowska M; Guzicka-Kazimierczak R; Joks M; Grosicki S; Ciepłuch H; Rymko M; Vesole DH; Castillo JJ
    Br J Haematol; 2016 Dec; 175(5):884-891. PubMed ID: 27682187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
    Kazmi SM; Nusrat M; Gunaydin H; Cornelison AM; Shah N; Kebriaei P; Nieto Y; Parmar S; Popat UR; Oran B; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH; Bashir Q
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):687-93. PubMed ID: 26361647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Validation of SKY92 and Its Combination With ISS in an Independent Cohort of Patients With Multiple Myeloma.
    van Beers EH; van Vliet MH; Kuiper R; de Best L; Anderson KC; Chari A; Jagannath S; Jakubowiak A; Kumar SK; Levy JB; Auclair D; Lonial S; Reece D; Richardson P; Siegel DS; Stewart AK; Trudel S; Vij R; Zimmerman TM; Fonseca R
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):555-562. PubMed ID: 28735890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New staging systems can predict prognosis of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation as first-line therapy.
    Kim H; Sohn HJ; Kim S; Kim K; Lee JH; Bang SM; Kim DH; Sohn SK; Lee JJ; Suh C
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):837-44. PubMed ID: 16864054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incorporation of the bone marker carboxy-terminal telopeptide of type-1 collagen improves prognostic information of the International Staging System in newly diagnosed symptomatic multiple myeloma.
    Jakob C; Sterz J; Liebisch P; Mieth M; Rademacher J; Goerke A; Heider U; Fleissner C; Kaiser M; von Metzler I; Müller C; Sezer O
    Leukemia; 2008 Sep; 22(9):1767-72. PubMed ID: 18580957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
    Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
    Kasamatsu T; Ozaki S; Saitoh T; Konishi J; Sunami K; Itagaki M; Asaoku H; Cho T; Handa H; Hagiwara S; Wakayama T; Negoro A; Takezako N; Harada N; Kuroda Y; Nakaseko C; Miyake T; Inoue N; Hata H; Shimazaki C; Ohno T; Kuroda J; Murayama T; Kobayashi T; Abe M; Ishida T; Nagura E; Shimizu K
    Hematol Oncol; 2018 Dec; 36(5):792-800. PubMed ID: 30176173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk stratification model in elderly patients with multiple myeloma: clinical role of magnetic resonance imaging combined with international staging system and cytogenetic abnormalities.
    Song MK; Chung JS; Lee JJ; Lee JH; Song IC; Lee SM; Shin DY; Lee GW; Lee IS
    Acta Haematol; 2015; 134(1):7-16. PubMed ID: 25832367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.